BioVeris Files Delayed Annual Report BioVeris Corp. filed its delayed annual report with the Securities and Exchange Commission Monday, only days before a scheduled hearing by the Nasdaq Stock Market on whether to delist the Gaithersburg biotechnology company for failing to report earnings. &lt;FONT face="verdana,MS Sans Serif,arial,helvetica" size="-2"\ color="#666666"&gt;&lt;B&gt;-The Washington Post&lt;/B&gt;&lt;/FONT&gt;